secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cytek Biosciences, Inc. (CTKB)
CIK:        0001831915
Form:       8-K
Filed at:   2026-06-02T20:15:52+00:00
Accession:  0001193125-26-253538
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Cytek Biosciences SVP Global Sales Philippe Busque resigns effective June 5
---------------------------------------------------------------------------

- Philippe Busque, Ph.D., SVP Global Sales and Services, resigned effective June 5, 2026.
- Resignation is to pursue another career opportunity; not due to disagreement with company operations.
- No successor or interim appointment announced in the filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1831915/000119312526253538/0001193125-26-253538-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1831915/000119312526253538/d161903d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-253538

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer